AIM ImmunoTech Inc. (AIM) Insider Trading
Sector: Biotechnology · Market Cap: $7M · 0 insider purchases in the last 7 days
No open market insider purchases at AIM ImmunoTech Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track AIM on your watchlist.
Start for FreeAbout AIM ImmunoTech Inc. Insider Trading
1 insider at AIM ImmunoTech Inc. (AIM) has purchased stock in the past 90 days, totaling $12K across 3 transactions (57,000 shares).
The most recent purchase was by CEO Equels Thomas K on September 17, 2026 — a $5K buy of 24,000 shares at $0.21, bringing their total holdings to 126,822 shares.
This insider buying is notable given that AIM had no recorded open market purchases in the nine months before that.
AIM is in the Biotechnology sector within the Biotechnology industry with a market cap of $7M.
Track AIM insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.